1. Home
  2. ITGR vs HAE Comparison

ITGR vs HAE Comparison

Compare ITGR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integer Holdings Corporation

ITGR

Integer Holdings Corporation

HOLD

Current Price

$86.41

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$64.60

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITGR
HAE
Founded
1970
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
ITGR
HAE
Price
$86.41
$64.60
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$91.14
$86.00
AVG Volume (30 Days)
954.6K
876.4K
Earning Date
05-18-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.54
EPS
2.89
2.46
Revenue
$1,853,637,000.00
$910,373,000.00
Revenue This Year
$1.37
N/A
Revenue Next Year
$8.25
$5.46
P/E Ratio
$30.03
$26.57
Revenue Growth
7.98
N/A
52 Week Low
$62.00
$47.32
52 Week High
$127.56
$87.32

Technical Indicators

Market Signals
Indicator
ITGR
HAE
Relative Strength Index (RSI) 53.74 51.19
Support Level $83.08 $48.47
Resistance Level $87.54 $67.63
Average True Range (ATR) 3.67 1.93
MACD -0.14 1.15
Stochastic Oscillator 21.11 85.26

Price Performance

Historical Comparison
ITGR
HAE

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: